Harnessing Novel Biomarkers as Surrogate Endpoints That Are ‘Reasonably Able to Predict’`

Time: 12:01 pm
day: Conference Day One - Harnessing Novel Biomarkers 12pm


  • Discussing the latest advances in biomarker research and the process of identifying and validating novel biomarkers with predictive capabilities
  • Ensuring biomarkers can predict clinical development to characterize early clinical outcomes
  • Addressing key considerations for successful regulatory submissions, ensuring biomarker data reliability, and aligning with the expectations of regulatory authorities